<DOC>
	<DOC>NCT02776670</DOC>
	<brief_summary>The purpose of this study is to evaluate the clinical effectiveness of SYSTANE® BALANCE compared to REFRESH OPTIVE® Advanced in subjects with lipid-deficient dry eye.</brief_summary>
	<brief_title>Clinical Outcomes Following Treatment With SYSTANE® BALANCE</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>Willing and able to attend all study visits; Must sign an informed consent form; Bestcorrected visual acuity (BCVA) of 55 letters or better in each eye as assessed using an early treatment diabetic retinopathy study (ETDRS) chart; Willing to take study products as directed for entire study; Other protocolspecified inclusion criteria may apply. Women of childbearing potential who are pregnant, plan to become pregnant during the study, breast feeding, or not using adequate birth control methods; Contact lens use within 30 days prior to Screening Visit, or unwilling to avoid contact lens use during the course of the study; Use of medication excluded by the protocol; Diseases, illnesses, infections, or ocular abnormalities excluded by the protocol; Ocular surgeries or procedures excluded by the protocol; Other protocolspecified exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>